antibody-drug binding technology
Scope
Date
~
-
Bio & Pharma
Roche to use Biodyne’s tech for cervical cancer diagnostic kits
Roche, a Swiss multinational healthcare company, is set to use a South Korean company’s technology for cervical cancer diagnostic kits.Biodyne...
Jan 16, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
Orion to buy control of biotech startup LegoChem for $415 mn
South Korea’s snack and confectionery maker Orion Group has agreed to buy a controlling stake in LegoChem Biosciences Inc., a Korean biotech s...
Jan 15, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
OCI-Hanmi merger to create Korea’s Bayer: OCI Chairman
Merging into one team, OCI Group and Hanmi Pharmaceutical Group will leap forward to be a global novel drug manufacturing and biotechnology innova...
Jan 15, 2024 (Gmt+09:00)
-
Bio & Pharma
JW Pharma takes gout drug Epaminurad to Malaysia for phase 3
South Korea's JW Pharmaceutical Corp., announced on Monday that it has received approval from the Malaysian National Pharmaceutical Regulatory Age...
Jan 15, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion to expand Yuflyma supply network in Europe
South Korea’s Celltrion Inc. announced on Friday that it will supply its biosimilar Yuflyma (active ingredient: adalimumab) for the treatment ...
Jan 12, 2024 (Gmt+09:00)
-
Korean innovators at CES 2024
Hyundai, Samsung-backed startups vie for spotlight at CES
LAS VEGAS – At CES, big tech names often take center stage but this is also a dream place for underdogs to become rising stars with unconventi...
Jan 11, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for interchangeability of Yuflyma in US
South Korea's Celltrion Inc. announced on Wednesday that it has applied to the US Food and Drug Administration (FDA) for a modified approval to repl...
Jan 10, 2024 (Gmt+09:00)
-
Bio & Pharma
Kobiolabs gets US patent for oral obesity drug candidate
Kobiolabs Co., a South Korean microbiome-based new drug development company, announced on Wednesday that it has a patent for Roseburia intestinalis ...
Jan 10, 2024 (Gmt+09:00)
-
Korean innovators at CES 2024
Samsung, Harman move in lockstep to advance in-vehicle technology
LAS VEGAS – South Korea’s tech giant Samsung Electronics Co. and its wholly owned US subsidiary Harman International Industries Inc. hav...
Jan 10, 2024 (Gmt+09:00)
-
Bio & Pharma
LG Chem out-licenses obesity drug candidate to US firm
LG Chem Ltd. has agreed to license out a rare genetic obesity drug candidate in phase 2 clinical trials to Rhythm Pharmaceuticals Inc., a US biotech...
Jan 05, 2024 (Gmt+09:00)
-
Bio & Pharma
SK Biopharm, Dong-A ST sign licensing deal of Cenobamate
South Korea's SK Biopharmaceuticals Co. announced on Thursday that it has signed a contract with Dong-A ST to transfer the rights to commercialize t...
Jan 04, 2024 (Gmt+09:00)
-
Korean innovators at CES 2024
Samsung to unveil new Odyssey gaming monitors at CES
Samsung Electronics Co. announced on Wednesday that it will unveil new Odyssey OLED gaming monitors at CES 2024, the world's largest IT and consum...
Jan 03, 2024 (Gmt+09:00)
-
Bio & Pharma
MedPacto gets FDA OK for colorectal cancer drug clinical trial
South Korea's biotech company MedPacto Inc. announced on Tuesday that it has got approval from the US Food and Drug Administration (FDA) for its I...
Jan 03, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
Celltrion to sell portfolio of Takeda drugs to CBC Group
South Korea’s Celltrion Inc. will divest of a portfolio of Takeda Pharmaceutical's prescription medicines sold in Asia to CBC Group, a Singapo...
Jan 01, 2024 (Gmt+09:00)
-
Automobiles
Hyundai Mobis' auto parts sweep safety, technology awards
South Korean auto parts maker Hyundai Mobis Co. said Thursday that 10 of its new technologies received or or are finalists for awards from external ...
Dec 28, 2023 (Gmt+09:00)
-
Bio & Pharma
ViGenCell, NK/T cell lymphoma treatment ‘VT-EBV-N’ designated as orphan drug in Europe
ViGenCell, a company specializing in immune cell therapy, announced on the 19th that its NK/T cell lymphoma treatment "VT-EBV-N" has been designated...
Dec 27, 2023 (Gmt+09:00)
-
Bio & Pharma
LegoChem Bio, Janssen sign $1.7 bn ADC licensing deal
LegoChem Biosciences Inc. has signed a blockbuster $1.7 billion deal to license out its proprietary antibody drug conjugate (ADC) candidate to Jasse...
Dec 26, 2023 (Gmt+09:00)
-
Bio & Pharma
J&J seeks US, European approval for drug developed with Yuhan
Global healthcare giant Johnson & Johnson is seeking approval for a lung cancer drug developed with Yuhan Corp., bringing the South Korean pha...
Dec 22, 2023 (Gmt+09:00)
-
Korean innovators at CES 2024
Hyundai Motor’s themes at CES 2024: Hydrogen, software
South Korea’s top automaker Hyundai Motor Co. is set to present its blueprint for a hydrogen energy ecosystem and software under the theme of ...
Dec 21, 2023 (Gmt+09:00)
-
Bio & Pharma
Boryung, HK inno.N to co-market Kanarb, K-CAB
South Korea’s pharmaceutical companies Boryung Corp. and HK inno.N announced on Wednesday that they will start co-marketing for their respec...
Dec 20, 2023 (Gmt+09:00)
-
Bio & Pharma
Icure wins $2.85 mn lidocaine cataplasm order from Guatemala
South Korea's Icure Pharmaceutical Incorporation announced on Tuesday that it signed a supply contract for the specialized local anesthetic lidoca...
Dec 19, 2023 (Gmt+09:00)
-
Tech, Media & Telecom
SK Telecom, Thales jointly strengthen 5G security
South Korea's SK Telecom Co. announced on Tuesday that it collaborated with global data security company Thales for 5G security.According to the com...
Dec 19, 2023 (Gmt+09:00)
-
Korean chipmakers
Samsung, ASML to build joint research plant in Hwaseong
Samsung Electronics Co. and ASML Holding NV plan to build their joint research plant in Dongtan township in Hwaseong, South Korea, in which the me...
Dec 15, 2023 (Gmt+09:00)
-
Artificial intelligence
AI, cloud to rule video surveillance market in 2024: Hanwha Vision
Hanwha Vision Co., formerly Hanwha Techwin, expects the global video surveillance market to undergo a major upgrade with the development of artifici...
Dec 13, 2023 (Gmt+09:00)
-
Korean chipmakers
ASML, Samsung to build R&D center in Korea for $760 mn
AMSTERDAM, Netherlands -- Samsung Electronics Co. and ASML Holding N.V. have reached a preliminary agreement to build a research and development fac...
Dec 13, 2023 (Gmt+09:00)
-
Bio & Pharma
HK inno.N reveals differentiated clinical results for K-CAB
South Korean bio-health company HK inno.N has been expanding its market by steadily announcing differentiated clinical results for its gastroesophag...
Dec 12, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion’s Vegzelma listed on US PBM preferred drug list
South Korea's Celltrion Healthcare Co. announced on Tuesday that its anti-cancer biosimilar Vegzelma (active ingredient: bevacizumab) was listed as ...
Dec 12, 2023 (Gmt+09:00)
-
Automobiles
Hyundai, Kia unveil snow tire-transforming technology
Hyundai Motor Co. and Kia Corp. unveiled a tire technology that can transform regular tires into snow tires with the simple push of a button, the co...
Dec 11, 2023 (Gmt+09:00)
-
Bio & Pharma
ISU Abxis gets patent for Alzheimer drug candidate in Taiwan
South Korea's ISU Abxis Co. announced on Friday that its Alzheimer's treatment candidate ISU203 has received a substance patent registration decisio...
Dec 08, 2023 (Gmt+09:00)
-
Batteries
LG, Poland’s ICPT in mega-million-dollar battery module supply deal
South Korea’s LG Energy Solution Ltd. said on Friday it has signed a multiyear deal to supply battery modules to Poland’s Impact Clean P...
Dec 08, 2023 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand